Pharma & Biotech
Acasti Pharma edging closer to commercializing CaPre as it eyes topline clinical data for Christmas
Orgenesis leads the charge at an exciting time for cell therapy
Hemispherx Biopharma takes cancer war to new stage with drug Ampligen
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.